North America Self-monitoring Blood Glucose Market Share

Statistics for the 2023 & 2024 North America Self-monitoring Blood Glucose market share, created by Mordor Intelligence™ Industry Reports. North America Self-monitoring Blood Glucose share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of North America Self-monitoring Blood Glucose Industry

The North America Self-monitoring Blood Glucose Market is fragmented, with a few major manufacturers having a global market presence. In contrast, the remaining manufacturers are confined to local or region-specific manufacturers. Mergers and acquisitions that occurred between the players in the recent past have helped companies strengthen their market presence. Panasonic acquired Bayer’s diabetes care unit and named it Ascensia diabetes care, which continued its operations in North America.

North America Self-monitoring Blood Glucose Market Leaders

  1. Ascensia

  2. Arkray

  3. Abbott

  4. F. Hoffmann-La Roche AG

  5. Platinum Equity (LifeScan)

*Disclaimer: Major Players sorted in no particular order

North America Self-monitoring Blood Glucose Market Concentration

NORTH AMERICA SELF-MONITORING BLOOD GLUCOSE MARKET Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)